| Smiles R Us Dental Care | |
|
407 W Lafayette St Bolivar TN 38008-2651 | |
| (731) 658-6112 | |
| (731) 658-6059 |
| Full Name | Smiles R Us Dental Care |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 407 W Lafayette St, Bolivar, Tennessee |
| Authorized Official Name and Position | Anita Jo Parks (DENTIST) |
| Authorized Official Contact | 7316586112 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Smiles R Us Dental Care 407 W Lafayette St Bolivar TN 38008-2651 Ph: (731) 658-6112 | Smiles R Us Dental Care 407 W Lafayette St Bolivar TN 38008-2651 Ph: (731) 658-6112 |
| NPI Number | 1982734596 |
|---|---|
| Provider Enumeration Date | 03/06/2007 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982734596 | NPI | - | NPPES |
| 160348 | Other | TN | DELTA DENTAL |
| 4108150 | Other | TN | BLUE CROSS BLUE SHIELD |
| 16438 | Medicaid | TN | |
| 1764104 | Other | PA | UNITED CONCORDIA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 7263 (Tennessee) | Primary |
News Archive
Based on the results of a pooled analysis of 11 unrelated randomized clinical trials investigating vitamin D supplementation and fracture risk in more than 31,000 older adults, Bess Dawson-Hughes, MD, director of the Bone Metabolism Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University, says higher doses of Vitamin D may be the most beneficial in reducing bone fractures in this age group.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Fred Hutchinson Cancer Research Center has received a pledge of $10 million to advance the promising field of immunotherapy research to treat and cure cancer, even in late stages.
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria
› Verified 9 days ago